Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.820
+0.060 (3.41%)
At close: Jul 2, 2026, 4:00 PM EDT
1.803
-0.017 (-0.94%)
After-hours: Jul 2, 2026, 7:58 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $180.51 million as of July 2, 2026. Its market cap has increased by 67.32% in one year.
Market Cap
180.51M
Enterprise Value
88.83M
1-Year Change
67.32%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $180.51M, a decrease of -79.68%. That is a compound annual growth rate of -27.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 180.51M | 21.46% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 187.73M |
| OnKure Therapeutics | 184.20M |
| Milestone Pharmaceuticals | 182.31M |
| LENZ Therapeutics | 178.09M |
| AN2 Therapeutics | 174.32M |
| Corbus Pharmaceuticals Holdings | 173.79M |
| Innate Pharma | 173.66M |
| NRx Pharmaceuticals | 171.41M |